← Leaderboards
Shideng Bao
Cleveland Clinic Lerner Com-Cwru
$9,894,339
Attributed
$10,160,577
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,160,577 · 7
By mechanism
R01$10,160,577 · 7
Top collaborators
- James R Connor1 shared
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Jennifer S Yu$6,177,422
- Jeongwu Lee$5,183,445
- Tyler Eugene Miller$823,129
- Anita Borton Hjelmeland$6,940,856
- Ryan Christopher Gimple$189,104
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTumor GrowthResistanceGlioblastomaMediatingMalignant NeoplasmsTumorStem CellsGliomaPlayTreatment EfficacyGrowthPrimary Brain NeoplasmsXenograft ProcedureCancer CellIn VivoTherapy ResistantRecurrenceTherapeutic TargetMolecularPreclinical StudyRadiationPhenotypeSelf-Renewal
Grant awards (28)
Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma$402,500
R01 · FY2025 · NS · contact PI
Macrophage-based Therapy and Immune Checkpoint Blockade for Glioblastoma$368,288
R01 · FY2025 · CA · contact PI
Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma$390,425
R01 · FY2024 · NS · contact PI
Macrophage-based Therapy and Immune Checkpoint Blockade for Glioblastoma$349,874
R01 · FY2024 · CA · contact PI
Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma$402,500
R01 · FY2023 · NS · contact PI
Macrophage-based Therapy and Immune Checkpoint Blockade for Glioblastoma$368,288
R01 · FY2023 · CA · contact PI
Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma$402,500
R01 · FY2022 · NS · contact PI
Ubiquitination and Deubiquitination of c-Myc in Glioblastoma$346,719
R01 · FY2020 · NS · contact PI
Glioblastoma stem cell-derived pericytes and cancer invasion$346,719
R01 · FY2020 · NS · contact PI
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells$351,691
R01 · FY2019 · CA · contact PI
Ubiquitination and Deubiquitination of c-Myc in Glioblastoma$346,719
R01 · FY2019 · NS · contact PI
Glioblastoma stem cell-derived pericytes and cancer invasion$346,719
R01 · FY2019 · NS · contact PI
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells$362,569
R01 · FY2018 · CA · contact PI
Glioblastoma stem cell-derived pericytes and cancer invasion$346,719
R01 · FY2018 · NS · contact PI
Ubiquitination and Deubiquitination of c-Myc in Glioblastoma$346,719
R01 · FY2018 · NS · contact PI
Targeting Ferritin in Glioblastoma$532,477
R01 · FY2017 · CA · contact PI
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells$362,569
R01 · FY2017 · CA · contact PI
Ubiquitination and Deubiquitination of c-Myc in Glioblastoma$346,719
R01 · FY2017 · NS · contact PI
Glioblastoma stem cell-derived pericytes and cancer invasion$346,719
R01 · FY2017 · NS · contact PI
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells$362,569
R01 · FY2016 · CA · contact PI
Ubiquitination and Deubiquitination of c-Myc in Glioblastoma$346,719
R01 · FY2016 · NS · contact PI
Glioblastoma stem cell-derived pericytes and cancer invasion$346,719
R01 · FY2016 · NS · contact PI
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells$362,569
R01 · FY2015 · CA · contact PI
Molecular Targeting of L1CAM to Inhibit Glioblastoma Stem Cell Invasion$333,203
R01 · FY2014 · NS · contact PI
Molecular Targeting of L1CAM to Inhibit Glioblastoma Stem Cell Invasion$324,789
R01 · FY2013 · NS · contact PI
Molecular Targeting of L1CAM to Inhibit Glioblastoma Stem Cell Invasion$336,569
R01 · FY2012 · NS · contact PI
Molecular Targeting of L1CAM to Inhibit Glioblastoma Stem Cell Invasion$336,569
R01 · FY2011 · NS · contact PI
Molecular Targeting of L1CAM to Inhibit Glioblastoma Stem Cell Invasion$343,438
R01 · FY2010 · NS · contact PI